DisGeNET is a knowledge management platform that integrates and standardizes the data of genes and mutations related to diseases from multiple sources. It covers entire range of human disease.
Source | Last Updated |
---|---|
DisGeNET | July 29, 2024 |
Disease ID | Disease Name ▼ | Gene Symbol | Gene ID | Gene Name | UniProt ID |
---|---|---|---|---|---|
C1306459 | Primary malignant neoplasm | CYP2U1 | 113612 | cytochrome P450 family 2 subfamily U member 1 | Q7Z449 |
C1306459 | Primary malignant neoplasm | ACOT7 | 11332 | acyl-CoA thioesterase 7 | O00154 |
C1306459 | Primary malignant neoplasm | FBXO17 | 115290 | F-box protein 17 | Q96EF6 |
C1306459 | Primary malignant neoplasm | ADH1C | 126 | alcohol dehydrogenase 1C (class I), gamma polypeptide | P00326 |
C1306459 | Primary malignant neoplasm | CPM | 1368 | carboxypeptidase M | P14384 |
C1306459 | Primary malignant neoplasm | CPT1B | 1375 | carnitine palmitoyltransferase 1B | Q92523 |
C1306459 | Primary malignant neoplasm | ADH6 | 130 | alcohol dehydrogenase 6 (class V) | P28332 |
C1306459 | Primary malignant neoplasm | CD109 | 135228 | CD109 molecule | Q6YHK3 |
C1306459 | Primary malignant neoplasm | VCAN | 1462 | versican | P13611 |
C1306459 | Primary malignant neoplasm | ADH4 | 127 | alcohol dehydrogenase 4 (class II), pi polypeptide | P08319 |
C1306459 | Primary malignant neoplasm | ADH5 | 128 | alcohol dehydrogenase 5 (class III), chi polypeptide | P11766 |
C1306459 | Primary malignant neoplasm | CRYBG3 | 131544 | crystallin beta-gamma domain containing 3 | Q68DQ2 |
C1306459 | Primary malignant neoplasm | SGPP2 | 130367 | sphingosine-1-phosphate phosphatase 2 | Q8IWX5 |
C1306459 | Primary malignant neoplasm | LAYN | 143903 | layilin | Q6UX15 |
C1306459 | Primary malignant neoplasm | CSPG4 | 1464 | chondroitin sulfate proteoglycan 4 | Q6UVK1 |
C1306459 | Primary malignant neoplasm | CYP1A1 | 1543 | cytochrome P450 family 1 subfamily A member 1 | P04798 |
C1306459 | Primary malignant neoplasm | PLB1 | 151056 | phospholipase B1 | Q6P1J6 |
C1306459 | Primary malignant neoplasm | CYP1A2 | 1544 | cytochrome P450 family 1 subfamily A member 2 | P05177 |
C1306459 | Primary malignant neoplasm | CYP3A5 | 1577 | cytochrome P450 family 3 subfamily A member 5 | P20815 |
C1306459 | Primary malignant neoplasm | CYP17A1 | 1586 | cytochrome P450 family 17 subfamily A member 1 | P05093 |
C1306459 | Primary malignant neoplasm | CYP27B1 | 1594 | cytochrome P450 family 27 subfamily B member 1 | O15528 |
C1306459 | Primary malignant neoplasm | MDGA2 | 161357 | MAM domain containing glycosylphosphatidylinositol anchor 2 | Q7Z553 |
C1306459 | Primary malignant neoplasm | DCN | 1634 | decorin | P07585 |
C1306459 | Primary malignant neoplasm | DBT | 1629 | dihydrolipoamide branched chain transacylase E2 | P11182 |
C1306459 | Primary malignant neoplasm | DGKA | 1606 | diacylglycerol kinase alpha | P23743 |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.0.0
Last updated: August 19, 2024